EN
中文 EN
A tumor-informed, cfDNA personalized MRD detection solution.
In combination with tumor-normal WES, CanCatch® PROPHET selects 50 patient specific variants to create tumor informed personalized panels.
Provides 100,000x mean coverage (ultra-deep sequencing) for ultra-high sensitivity.
Key Features and Benefits

Whole Exome Scanning

Baseline WES testing supports fusion,

TMB, MSl, and HLA test


Under Personalized Panel Design

50 Patient-specific somatic variants

100,000x Ultra-deep sequencing


Dynamic Monitoring

Surveillance and

landmark visualized monitoring

Performance Validations
Clinical Trial Studies



brPROPHET



● CanCatch® PROPHET outperforms fixed-panel MRD assays in head-to-head comparison in NSCLC.


● CanCatch® PROPHET illustrates a median lead time of 299 days to radiological recurrence.

● TNMB stage, integrating landmark cDNA MRD and TNM, improves prognosis prediction.

● Post-relapse cDNA status facilitates decision on later lines of treatment.




Download Our Product Brochure Here Contact Us
Contact Our Biopharma Team to Learn More
Biomarker Discovery & Translational Research
Clinical Trial Design & Patient Recruitment
Global Capabilities for Clinical Studies
CDx Development & Commercialization
Genomic Data Solutions
ctDNA Monitoring Portfolio
Other
I also want to receive general marketing communications from Burning Rock Dx in addition to the specific information requested here. You may unsubscribe from receiving such general marketing communications at any time.
*Required
By submitting this form, or by checking the box above the “Submit” button (if applicable), you agree that your information will be processed according to Burning Rock’s privacy policy to provide you with the information and/or general marketing communications (if applicable) you have requested here. Burning Rock Dx is committed to protecting and respecting your privacy.
Contact Our Experts
We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."